API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
21
PharmaCompass offers a list of Harpagoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Harpagoside manufacturer or Harpagoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Harpagoside manufacturer or Harpagoside supplier.
PharmaCompass also assists you with knowing the Harpagoside API Price utilized in the formulation of products. Harpagoside API Price is not always fixed or binding as the Harpagoside Price is obtained through a variety of data sources. The Harpagoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Harpagoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Harpagoside, including repackagers and relabelers. The FDA regulates Harpagoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Harpagoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Harpagoside supplier is an individual or a company that provides Harpagoside active pharmaceutical ingredient (API) or Harpagoside finished formulations upon request. The Harpagoside suppliers may include Harpagoside API manufacturers, exporters, distributors and traders.
click here to find a list of Harpagoside suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Harpagoside CEP of the European Pharmacopoeia monograph is often referred to as a Harpagoside Certificate of Suitability (COS). The purpose of a Harpagoside CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Harpagoside EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Harpagoside to their clients by showing that a Harpagoside CEP has been issued for it. The manufacturer submits a Harpagoside CEP (COS) as part of the market authorization procedure, and it takes on the role of a Harpagoside CEP holder for the record. Additionally, the data presented in the Harpagoside CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Harpagoside DMF.
A Harpagoside CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Harpagoside CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Harpagoside suppliers with CEP (COS) on PharmaCompass.
Harpagoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Harpagoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Harpagoside GMP manufacturer or Harpagoside GMP API supplier for your needs.
A Harpagoside CoA (Certificate of Analysis) is a formal document that attests to Harpagoside's compliance with Harpagoside specifications and serves as a tool for batch-level quality control.
Harpagoside CoA mostly includes findings from lab analyses of a specific batch. For each Harpagoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Harpagoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Harpagoside EP), Harpagoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Harpagoside USP).